Warp-Speed Covid-19 Vaccine Development: Beneficiaries of Maturation in Biopharmaceutical Technologies and Public-Private PartnershipsWarp-Speed Covid-19 백신 개발: 바이오제약 기술 및 민관 파트너십 성숙의 수혜자Article Published on 2021-02-012022-08-31 Journal: Journal of pharmaceutical sciences [Category] MERS, SARS, 신약개발, [키워드] activity anticipated approach approval beneficiary biopharmaceutical Biopharmaceutics Biotechology candidate clinical study clinical testing COVID-19 current develop Disease progression dose effective effective vaccine Effective vaccines Formulation Gene therapy Human immune response Infection less majority masking measure operation organized partnership platform Prevent resource Safe SARS-CoV2 service social distancing speed Stage supported sustained technology vaccine candidate Vaccines. while [DOI] 10.1016/j.xphs.2020.11.010 PMC 바로가기 [Article Type] Article